News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
728,825 Results
Type
Article (43174)
Company Profile (458)
Press Release (685181)
Multimedia
Podcasts (106)
Webinars (20)
Section
Business (209105)
Career Advice (2032)
Deals (36080)
Drug Delivery (108)
Drug Development (83810)
Employer Resources (174)
FDA (16587)
Job Trends (15162)
News (353652)
Policy (33236)
Tag
Academia (2648)
Accelerated approval (18)
Adcomms (28)
Allergies (118)
Alliances (51109)
ALS (141)
Alzheimer's disease (1609)
Antibody-drug conjugate (ADC) (229)
Approvals (16659)
Artificial intelligence (416)
Autoimmune disease (71)
Automation (27)
Bankruptcy (373)
Best Places to Work (11840)
BIOSECURE Act (20)
Biosimilars (150)
Biotechnology (331)
Bladder cancer (133)
Brain cancer (48)
Breast cancer (493)
Cancer (3844)
Cardiovascular disease (311)
Career advice (1712)
Career pathing (34)
CAR-T (231)
CDC (44)
Cell therapy (627)
Cervical cancer (31)
Clinical research (69917)
Collaboration (1348)
Company closure (4)
Compensation (928)
Complete response letters (50)
COVID-19 (2737)
CRISPR (78)
C-suite (580)
Cystic fibrosis (135)
Data (4509)
Decentralized trials (2)
Denatured (34)
Depression (104)
Diabetes (421)
Diagnostics (6593)
Digital health (34)
Diversity (10)
Diversity, equity & inclusion (45)
Drug discovery (195)
Drug pricing (164)
Drug shortages (29)
Duchenne muscular dystrophy (202)
Earnings (90007)
Editorial (49)
Employer branding (21)
Employer resources (152)
Events (118904)
Executive appointments (954)
FDA (19004)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (15)
Funding (1220)
Gene editing (167)
Generative AI (31)
Gene therapy (512)
GLP-1 (904)
Government (4694)
Grass and pollen (5)
Guidances (346)
Healthcare (19188)
HIV (44)
Huntington's disease (36)
IgA nephropathy (63)
Immunology and inflammation (220)
Immuno-oncology (18)
Indications (53)
Infectious disease (2961)
Inflammatory bowel disease (178)
Inflation Reduction Act (16)
Influenza (94)
Intellectual property (188)
Interviews (315)
IPO (16896)
IRA (51)
Job creations (3710)
Job search strategy (1438)
Kidney cancer (15)
Labor market (71)
Layoffs (565)
Leadership (29)
Legal (8014)
Liver cancer (87)
Longevity (11)
Lung cancer (557)
Lymphoma (263)
Machine learning (30)
Management (59)
Manufacturing (589)
MASH (135)
Medical device (13754)
Medtech (13777)
Mergers & acquisitions (20055)
Metabolic disorders (1066)
Multiple sclerosis (133)
NASH (19)
Neurodegenerative disease (213)
Neuropsychiatric disorders (57)
Neuroscience (2605)
NextGen: Class of 2025 (6758)
Non-profit (4563)
Now hiring (57)
Obesity (509)
Opinion (260)
Ovarian cancer (133)
Pain (154)
Pancreatic cancer (167)
Parkinson's disease (235)
Partnered (27)
Patents (404)
Patient recruitment (314)
Peanut (53)
People (59634)
Pharmaceutical (85)
Pharmacy benefit managers (24)
Phase I (21956)
Phase II (30842)
Phase III (22800)
Pipeline (2697)
Policy (255)
Postmarket research (2602)
Preclinical (9420)
Press Release (67)
Prostate cancer (195)
Psychedelics (50)
Radiopharmaceuticals (275)
Rare diseases (637)
Real estate (6045)
Recruiting (70)
Regulatory (23938)
Reports (51)
Research institute (2446)
Resumes & cover letters (353)
Rett syndrome (15)
RNA editing (15)
RSV (64)
Schizophrenia (131)
Series A (205)
Series B (156)
Service/supplier (11)
Sickle cell disease (80)
Special edition (24)
Spinal muscular atrophy (154)
Sponsored (35)
Startups (3789)
State (2)
Stomach cancer (15)
Supply chain (93)
Tariffs (80)
The Weekly (70)
Vaccines (927)
Venture capital (65)
Weight loss (335)
Women's health (56)
Worklife (18)
Date
Today (116)
Last 7 days (709)
Last 30 days (2524)
Last 365 days (31485)
2025 (25108)
2024 (36300)
2023 (41015)
2022 (52277)
2021 (56763)
2020 (54920)
2019 (47416)
2018 (35696)
2017 (33023)
2016 (32346)
2015 (38396)
2014 (32185)
2013 (27109)
2012 (29221)
2011 (29863)
2010 (27992)
Location
Africa (744)
Alabama (77)
Alaska (7)
Arizona (275)
Arkansas (14)
Asia (40099)
Australia (6662)
California (9296)
Canada (2832)
China (868)
Colorado (392)
Connecticut (411)
Delaware (257)
Europe (87864)
Florida (1370)
Georgia (300)
Hawaii (2)
Idaho (60)
Illinois (728)
India (45)
Indiana (440)
Iowa (20)
Japan (319)
Kansas (120)
Kentucky (35)
Louisiana (18)
Maine (68)
Maryland (1224)
Massachusetts (6909)
Michigan (282)
Minnesota (537)
Mississippi (4)
Missouri (110)
Montana (31)
Nebraska (25)
Nevada (103)
New Hampshire (76)
New Jersey (2565)
New Mexico (30)
New York (2517)
North Carolina (1322)
North Dakota (9)
Northern California (4276)
Ohio (281)
Oklahoma (20)
Oregon (40)
Pennsylvania (1946)
Puerto Rico (18)
Rhode Island (44)
South America (1113)
South Carolina (48)
South Dakota (1)
Southern California (3564)
Tennessee (146)
Texas (1429)
United States (33890)
Utah (272)
Virginia (226)
Washington D.C. (78)
Washington State (790)
West Virginia (4)
Wisconsin (82)
Wyoming (1)
728,825 Results for "serina therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Serina Therapeutics Draws First $5 Million Funding Tranche to Support Registrational Trial of SER-252 in Parkinson’s Disease
October 6, 2025
·
3 min read
Press Releases
Serina Therapeutics to Present at the BTIG Virtual Biotechnology Conference
July 28, 2025
·
3 min read
Press Releases
Serina Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
September 8, 2025
·
3 min read
Press Releases
Serina Therapeutics Secures Up to $20 Million to Advance Registrational Trial of SER-252 in Parkinson’s Disease
September 10, 2025
·
7 min read
Press Releases
Serina Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights
August 12, 2025
·
14 min read
Press Releases
Serina Therapeutics Announces Date for 2025 Annual Stockholders Meeting
July 1, 2025
·
4 min read
Press Releases
Serina Therapeutics Advances POZ-VMAT2i into Development for Tardive Dyskinesia (TD)
July 29, 2025
·
5 min read
Press Releases
Serina Therapeutics to Present at FORCE Family Office Investor Webinar on June 26, 2025
June 24, 2025
·
4 min read
Press Releases
Serina Therapeutics Announces FDA Feedback Supports Registrational Trial Design of SER-252 in Advanced Parkinson’s Disease under 505(b)(2) NDA Pathway
August 26, 2025
·
7 min read
Press Releases
Serina Therapeutics Appoints Stephen Brannan, M.D. to Board of Directors
May 23, 2025
·
3 min read
1 of 72,883
Next
